Key result
Pre-ablation ECLM metrics predict early AF recurrence with 0.89 AUC using an SVM classifier.
Why the study?
Effective treatment of AF remains clinically challenging due to complex electrophysiological patterns, prompting exploration of noninvasive Electromechanical Cycle Length Mapping to inform long-term ablation response.
Does Electromechanical Cycle Length Mapping (ECLM) accurately predict 3-month arrhythmia recurrence in patients undergoing first-time cardiac ablation for atrial fibrillation or flutter?
Observational (n=22)
Does Electromechanical Cycle Length Mapping (ECLM) accurately predict 3-month arrhythmia recurrence in patients undergoing first-time cardiac ablation for atrial fibrillation or flutter?
Non-invasive Electromechanical Cycle Length Mapping (ECLM) using high-framerate ultrasound shows strong feasibility in identifying arrhythmic triggers and predicting 3-month recurrence after first-time AF ablation.
ECLM may aid recurrence prediction after AF ablation; leaves open clinical utility pending larger prospective validation.
Effective treatment of atrial fibrillation (AF) remains a clinical challenge due to its complex electrophysiological patterns. This study explores the feasibility of Electromechanical Cycle Length Mapping (ECLM), a noninvasive, high-framerate 2D-ultrasound imaging technique, to map and quantify AF electromechanical cycle length (CL) activity and inform on long-term ablation procedure response. 16 AF and six Atrial Flutter subjects were imaged pre- and post-successful first-time cardiac ablation. Pre-ablation ECLM maps identified the location of arrhythmic triggers in 100% of the subjects and showcased their reduction post-ablation. Patient monitoring revealed five AF subjects reverted to arrhythmia within the first 3-months. Pre-ablation CL dispersion values were an independent predictor of the 3-month AF recurrence (multivariate logistic regression AUC of 0.78). In addition, a Support Vector Machine (SVM) classifier trained on the ECLM-derived metrics distinguished 3-month responders (AUC of 0.89). These findings support the key role ECLM could play in immediate atrial arrhythmia evaluation and treatment response prediction.
No takes yet. Share an insight, caveat, or question.
Tourni et al. (2024) conducted an observational in Atrial fibrillation and Atrial Flutter (n=22). Electromechanical Cycle Length Mapping (ECLM) was evaluated on Prediction of 3-month AF recurrence (AUC 0.89). Pre-ablation Electromechanical Cycle Length Mapping (ECLM) metrics predicted 3-month atrial fibrillation recurrence with an AUC of 0.89 using a Support Vector Machine classifier.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: